Compare stocks

SKAN Group AG is engaged in the design and manufacture of advanced cleanroom equipment and solutions, primarily servicing the pharmaceutical and biotechnology industries. It specializes in the development of isolator technology used for aseptic production processes, providing critical equipment that ensures sterile manufacturing environments. Founded in 1968, SKAN is headquartered in Allschwil, Switzerland, and has established a strong presence across the global market, including locations in North America, Europe, and Asia. The company's strategic focus lies in its expertise in containment solutions and decontamination processes, which positions it as a key player in supporting its clients’ compliance with stringent safety and quality regulations. SKAN's innovative approach and specialized knowledge have made its products integral to various high-tech pharmaceutical production lines.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.